---
title: "Revelation Biosciences - CW27 | 8-K: FY2025 Q2 EPS: USD -7.01"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/252231674.md"
published_at: "2025-08-08T12:11:32.000Z"
---

# Revelation Biosciences - CW27 | 8-K: FY2025 Q2 EPS: USD -7.01

EPS: As of FY2025 Q2, the actual value is USD -7.01.

### Cash and Cash Equivalents

-   As of June 30, 2025, Revelation Biosciences, Inc. had $5.2 million in cash and cash equivalents, a decrease from $6.5 million as of December 31, 2024, primarily due to cash used for operating activities.

### Operating Cash Flow

-   Net cash used for operating activities for the three months ended June 30, 2025, was $4.7 million, compared to $5.3 million for the same period in 2024.

### Net Loss

-   The net loss for the three months ended June 30, 2025, was $2.4 million, or - $7.01 basic and diluted net loss per share, compared to a net loss of $8.4 million, or - $246.27 basic and diluted net loss per share for the same period in 2024.
-   For the six months ended June 30, 2025, the net loss was $4.5 million, or - $13.60 basic and diluted net loss per share, compared to a net loss of $11.1 million, or - $390.02 basic and diluted net loss per share for the same period in 2024.

### Operating Expenses

-   Total operating expenses for the three months ended June 30, 2025, were $2.5 million, compared to $2.5 million for the same period in 2024.
-   For the six months ended June 30, 2025, total operating expenses were $4.6 million, compared to $4.4 million for the same period in 2024.

### Outlook / Guidance

-   Revelation Biosciences, Inc. anticipates announcing data from the Phase 1b study of Gemini later this quarter and plans to engage with the FDA later this year to further the clinical development of Gemini.

### Related Stocks

- [REVBW.US - Revelation Biosciences - CW27](https://longbridge.com/en/quote/REVBW.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Advance Auto Parts’ Heavy Debt Load Raises Liquidity, Refinancing and Turnaround Risks | Advance Auto Parts Inc (AAP) is facing significant financial risks due to its heavy debt load, which may limit liquidity | [Link](https://longbridge.com/en/news/275997122.md) |
| Wall Street bullish on AtaiBeckley (ATAI), here’s why | Wall Street is optimistic about AtaiBeckley Inc. (NASDAQ:ATAI), identifying it as a top penny stock with a potential ups | [Link](https://longbridge.com/en/news/276000823.md) |
| Did Analyst Upgrades and Metal Price Tailwinds Just Shift Coeur Mining's (CDE) Investment Narrative? | Recent analyst upgrades for Coeur Mining, alongside rising gold and silver prices, have shifted focus on the company's c | [Link](https://longbridge.com/en/news/275995095.md) |
| Angi (ANGI) Valuation Check After Weak Q4 Results And Sharp Share Price Drop | Angi (ANGI) reported a 10.1% year-on-year revenue decline in Q4 2025, leading to a significant drop in share price. Desp | [Link](https://longbridge.com/en/news/275986898.md) |
| Envestnet Asset Management Inc. Cuts Stock Position in Edwards Lifesciences Corporation $EW | Envestnet Asset Management Inc. reduced its stake in Edwards Lifesciences Corporation by 23.1% in Q3, now holding 261,58 | [Link](https://longbridge.com/en/news/275999995.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.